HUNTINGTON BANCSHARES INC /MD/
For the period ended Sep 30, 2026. Filed Oct 27, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 27, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|
For the quarterly period ended September 30, 2026
OR
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|
For the transition period from to
(Exact name of registrant as specified in its charter)
| Maryland | 1-34073 | 31-0724920 |
|---|---|---|
| (State or other jurisdiction ofincorporation or organization) | (CommissionFile Number) | (I.R.S. EmployerIdentification No.) |
Registrant’s address:41 South High Street, Columbus, Ohio 43287
Registrant’s telephone number, including area code: (614)480-2265
Securities registered pursuant to Section 12(b) of the Act
| Title of each class | TradingSymbol(s) | Name of each exchange on which registered |
|---|---|---|
| Depositary Shares (each representing a 1/40th interest in a share of 4.500% Series H Non-Cumulative, perpetual preferred stock) | HBANP | The Nasdaq Stock Market LLC |
| Depositary Shares (each representing a 1/1000th interest in a share of 5.70% Series I Non-Cumulative, perpetual preferred stock) | HBANM | The Nasdaq Stock Market LLC |
| Depositary Shares (each representing a 1/40th interest in a share of 6.875% Series J Non-Cumulative, perpetual preferred stock) | HBANL | The Nasdaq Stock Market LLC |
| Depositary Shares (each representing a 1/1000th interest in a share of 5.50% Series L Non-Cumulative, perpetual preferred stock) | HBANZ | The Nasdaq Stock Market LLC |
| Common Stock—Par Value $0.01 per Share | HBAN | The Nasdaq Stock Market LLC |
| Nasdaq Texas, LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90
days. x Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period
that the registrant was required to submit such files). x Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | x | Accelerated filer | ☐ | |
|---|---|---|---|---|
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |
| Emerging growth company | ☐ | |||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).☐ Yesx No
There were 2,015,387,251 shares of the registrant’s common stock ($0.01 par value) outstanding on September 30, 2026.
2 Huntington Bancshares Incorporated
TABLE OF CONTENTS
HUNTINGTON BANCSHARES INCORPORATED
Form 10-Q for the quarter ended September 30, 2026
| Page Number | ||
|---|---|---|
| Glossary of Acronyms and Terms | 3 | |
| PART I. FINANCIAL INFORMATION | ||
| Item 1. | Financial Statements (Unaudited) | 40 |
| Consolidated Balance Sheets at September 30, 2026 and December 31, 2025 | 40 | |
| Consolidated Statements of Income for the three and nine months ended September 30, 2026 and 2025 | 41 | |
| Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2026 and 2025 | 42 | |
| Consolidated Statements of Changes in Shareholders’ Equity for the three and nine months ended September 30, 2026 and 2025 | 43 | |
| Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 | 45 | |
| Notes to Unaudited Consolidated Financial Statements: | 47 | |
| Note 1 - Basis of Presentation | 47 | |
| Note 2 - Accounting Standards Update | 47 | |
| Note 3 - Business Combinations | 47 | |
| Note 4 - Investment and Other Securities | 53 | |
| Note 5 - Loans and Leases | 57 | |
| Note 6 - Allowance for Credit Losses | 65 | |
| Note 7 - Mortgage Loan Sales and Servicing Rights | 66 | |
| Note 8 - Goodwill and Other Intangible Assets | 67 | |
| Note 9 - Borrowings | 67 | |
| Note 10 - Other Comprehensive Income | 69 | |
| Note 11 - Shareholders’ Equity | 71 | |
| Note 12 - Earnings Per Share | 72 | |
| Note 13 - Revenue from Contracts with Customers | 73 | |
| Note 14 - Fair Value of Assets and Liabilities | 74 | |
| Note 15 - Derivative Financial Instruments | 82 | |
| Note 16 - Variable Interest Entities | 86 | |
| Note 17 - Commitments and Contingent Liabilities | 88 | |
| Note 18 - Segment Reporting | 90 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 4 |
| Introduction | 4 | |
| Executive Overview | 4 | |
| Discussion of Results of Operations | 8 | |
| Risk Management: | 14 | |
| Credit Risk | 14 | |
| Market Risk | 21 | |
| Liquidity Risk | 24 | |
| Operational Risk | 28 | |
| Compliance Risk | 29 | |
| Capital | 29 | |
| Business Segment Discussion | 31 | |
| Additional Disclosures | 34 | |
| Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 92 |
| Item 4. | Controls and Procedures | 92 |
| PART II. OTHER INFORMATION | ||
| Item 1. | Legal Proceedings | 92 |
| Item 1A. | Risk Factors | 92 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 93 |
| Item 5. | Other Information | 93 |
| Item 6. | Exhibits | 94 |
| Signatures | 95 | |
2026 3Q Form 10-Q 3
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.